NCT05292989

Brief Summary

Frailty is a common clinical syndrome in older adults that may carry an increased risk for poor health outcomes including falls, hospitalisation, and mortality. Having a colonoscopy can be associated with potential adverse outcomes in frail patients. At present, however, frailty is not routinely assessed in gastroenterological clinical practice. In a prospective randomised controlled study consenting patients over 65 years at the Princess Alexandra Hospital will receive either a) personalised (tailored) approach that includes assessment of frailty and structured information provided to the consumer or b) current standard practice in regards to having a surveillance colonoscopy to determine the effects on patient satisfaction and percentage of colonoscopies avoided.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 1, 2022

Completed
22 days until next milestone

First Posted

Study publicly available on registry

March 23, 2022

Completed
1.4 years until next milestone

Study Start

First participant enrolled

August 14, 2023

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2026

Completed
Last Updated

August 1, 2025

Status Verified

July 1, 2025

Enrollment Period

2.5 years

First QC Date

March 1, 2022

Last Update Submit

July 29, 2025

Conditions

Keywords

colonoscopy surveillance

Outcome Measures

Primary Outcomes (4)

  • Satisfaction with the respective outpatient service.

    'Based only upon your recent experience when you received a consultation in relation to a potential future endoscopic test, how likely are you to recommend the respective health care organization (PAH or RWBH) to a friend, family member or colleague?.' Please rate your experience on a scale of 1 to 10, where 1 is extremely unlikely and 10 extremely likely.

    Week 0

  • Patient satisfaction questions

    Patients will be asked Overall, how would you rate the care you received? 1. Very good 2. Good 3. Adequate 4. Poor 5. Very poor Were you involved as much as you wanted to be in decisions about your care and treatment? 1. Yes, definitely 2. Yes, to some extent 3. No, not enough How much information about your condition or treatment was given to you? 1. The right amount 2. Too much 3. Not enough

    Week 0

  • Comprehensive Endoscopy Satisfaction Tool

    This captures the overall satisfaction with the service events (endoscopic procedure and relevant components including the pre-procedure assessment). Higher scores greater satisfaction

    Week 2-4 After colonoscopy procedure

  • Percentage of consumers in the intervention and control group that are referred for a surveillance colonoscopies who decide not have the procedure based upon the information provided.

    • Percentage of consumers in the intervention and control group that are referred for a surveillance colonoscopies who decide not have the procedure based upon the information provided.

    Week 0-2 after consultation with doctor

Secondary Outcomes (2)

  • Number of participants with colorectal cancer related morbidity

    Colorectal cancer related morbidity within 5 years of the referral

  • Number of participants with non colorectal cancer related mortality information within 5 years of the referral

    Non colorectal cancer related mortality information within 5 years of the referral

Study Arms (2)

Group 1- Personalised tailored approach

EXPERIMENTAL

If patients are assigned to this group they will be asked to complete a frailty assessment which includes the Fraility Index short form, an assessment of grip strength, time to complete 5 sit-to-stands, balance test, and gait speed along with some questionnaires on comorbid medical condition. The treating Gastroenterologist will then go through the results of the frailty assessment with the patient and based on this information will discuss the benefits and risks associated with having a surveillance colonoscopy. The patient will then decide if they would like to go ahead with a surveillance colonoscopy and the treating Gastroenterologist will provide further advice as required. The frailty assessment is intended to be done at the time of the appointment with the specialist. However, operational requirements may dictate that e.g. a telehealth delivered occasion of service is done at a separate date.

Other: Frailty Assessment

Group 2- Standard Care

PLACEBO COMPARATOR

Patients assigned to this group will discuss the benefits and risks associated with having a surveillance colonoscopy with the treating Gastroenterologist and will decide whether to proceed with the colonoscopy.

Other: Standard Care

Interventions

Personalised (tailored) approach that includes assessment of frailty and structured information provided to the consumer

Group 1- Personalised tailored approach

Standard care practice

Group 2- Standard Care

Eligibility Criteria

Age65 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Patients aged over 65 years of age
  • Ability to understand the study instructions and answering questionnaires

You may not qualify if:

  • Inability to consent or participate in the assessments (e.g. frailty assessment) that are required as part of this project.
  • Lack of informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Princess Alexandra Hospital

Woolloongabba, Queensland, 4212, Australia

RECRUITING

MeSH Terms

Conditions

Gastrointestinal Diseases

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

Digestive System Diseases

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Deidentified data
Purpose
SCREENING
Intervention Model
PARALLEL
Model Details: Prospective randomized controlled trial design
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Gastroenterology & Hepatology

Study Record Dates

First Submitted

March 1, 2022

First Posted

March 23, 2022

Study Start

August 14, 2023

Primary Completion

February 1, 2026

Study Completion

February 1, 2026

Last Updated

August 1, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations